Navigation Links
Prix Galien USA Honors Innovation in Science and Biotech Industries
Date:10/1/2009

NEW YORK, Oct. 1 /PRNewswire-USNewswire/ -- The Prix Galien USA committee celebrated members of the science and biotechnology industries last night for the development and discovery of drugs and technologies that improve the human condition. Novartis Oncology, Amgen, GlaxoSmithKline and Veridex were honored with the 2009 Prix Galien USA, considered the industry's highest accolade for pharmaceutical research and development, for treatments that could change the course of health care worldwide.

"The 2009 Prix Galien USA winners represent what is possible when basic scientific research translates to drug development and discovery," said Gerald Weissmann, M.D., Prix Galien USA committee chair, NYU School of Medicine research professor of medicine, director of biotechnology study center, and editor-in-chief of The FASEB Journal. "We all benefit from the research that provides new treatments for the millions of cancer patients worldwide and for the patients living with rare blood diseases. Basic research translates into future knowledge and improved health for all of us."

At the gala awards ceremony, the committee presented Barry Bloom, Ph.D., Joan L. and Julius H. Jacobson professor of public health at the Harvard School of Public Health, and Jeffrey Sachs, Ph.D., director of The Earth Institute, Quetelet Professor of Sustainable Development, and professor of health policy and management at Columbia University, with the Pro Bono Humanum Award. Dr. Barry Bloom was honored for his work to support efforts to eradicate disease by understanding the immune responses to infectious diseases. Dr. Sachs was honored for the Millennium Villages, a project which has helped rural African communities and close to half a million people lift themselves out of extreme poverty by providing basic interventions that address needs in business development, food, health, infrastructure and education.

The Prix Galien 2009 winners, selected from 21 candidates, are:

Best Pharmaceutical Product:

  • Novartis Oncology, GLEEVEC(R) -- By targeting the specific cancer-causing molecules in the body, GLEEVEC(R)( )attacks cancerous cells while sparing healthy cells and the immune system.

Best Biotechnology Product:

  • Amgen, Nplate(R) -- A thrombopoietin receptor agonist used in the treatment of thrombocytopenic purpura by increasing platelet counts without affecting the immune system.
  • GlaxoSmithKline, PROMACTA(R) -- Approved for the treatment of thrombocytopenia, the product increases platelet levels and does not inhibit normal antibody production.

Best Medical Technology:

  • Veridex, CellSearch(R) CTC Test -- The device is used to enumerate tumor cells in whole blood, making it the first of its kind that is capable of reliably isolating and identifying cells in patients with metastatic breast, colorectal or prostate cancer.

The Prix Galien Award (www.prix-galien-usa.com) recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is considered the equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. The Prix Galien USA awards committee of 11 individuals includes seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals.

SOURCE Vanguard Communications


'/>"/>
SOURCE Vanguard Communications
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer
2. BIOCOMs 4th Annual DeviceFest Honors Companies
3. March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition
4. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
5. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
6. MJFFs Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinsons Disease
7. Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative
8. Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimers Disease
9. NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology
10. InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation
11. Wayne County Partners With TechTown to Launch Global Stem Cell Innovation and Commercialization Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
Breaking Medicine News(10 mins):